» Articles » PMID: 12601501

Antidepressant-like Effects in Various Mice Strains in the Forced Swimming Test

Overview
Specialty Pharmacology
Date 2003 Feb 26
PMID 12601501
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Strain differences in mice have been reported in response to drugs in the mouse forced swimming test (FST), even if few antidepressants were examined.

Objectives: The aim of the present study was to investigate the influence of genetic factors, using five antidepressants (imipramine, desipramine, citalopram, paroxetine and bupropion) in the mouse FST, in outbred strains (Swiss, NMRI) and inbred strains (DBA/2, C57BL/6J Rj). Moreover, whole brain levels of dopamine (DA), noradrenaline (NA), serotonin (5-HT) in vehicle treated animals, which were or were not subjected to the FST, were measured by HPLC analysis in an attempt to explain behavioural differences.

Methods: For each antidepressant, a dose range (1-16 mg/kg) was tested in the locomotor apparatus and only non-psychostimulant doses were then tested in the FST in order to detect antidepressant-like activity.

Results: No baseline differences among Swiss, NMRI, DBA/2 and C57BL/6J Rj strains were observed in our experiments, allowing the comparison of different antidepressants in each strain. Imipramine (16 mg/kg), desipramine, citalopram (4-16 mg/kg) and paroxetine (8 and 16 mg/kg) treatment decreased the immobility time in the Swiss strain and the size of the effect reached more than 20% for each of these antidepressants. C57BL/6J Rj was the only strain sensitive to bupropion (2 and 4 mg/kg). In the NMRI strain, only paroxetine treatment decreased the immobility time (16 mg/kg).

Conclusion: Our study showed that drug sensitivity is genotype dependent. FST results have shown that Swiss mice are the most sensitive strain to detect 5-HT and/or NA treatment. The use of DBA/2 inbred mice may be limited, as an absence of antidepressant-like response was observed in the FST. The lack of sensitivity to antidepressant treatment in DBA/2 strains could be due to high DA, NA and 5-HT whole brain concentrations.

Citing Articles

N-acetyl cysteine through modulation of HDAC and GCN in the hippocampus mitigates behavioral disorders in the first and second generations of socially isolated mice.

Asgharzadeh N, Diziche A, Amini-Khoei H, Yazdanpanahi N, Korrani M IBRO Neurosci Rep. 2025; 18:350-359.

PMID: 40051733 PMC: 11883397. DOI: 10.1016/j.ibneur.2025.01.014.


Stress-Easing Effect of Diacyl Glyceryl Ethers on Anxiety-Related Behavior in Mice.

Jiang R, Ohkubo T, Sato T, Sakai N Foods. 2024; 13(23).

PMID: 39682837 PMC: 11640430. DOI: 10.3390/foods13233765.


Yeast supplementation potentiates fluoxetine's anti-depressant effect in mice via modulation of oxido-inflammatory, CREB, and MAPK signaling pathways.

Potokiri A, Omeiza N, Ajayi A, Adeleke P, Alagbonsi A, Iwalewa E Curr Res Physiol. 2024; 7:100132.

PMID: 39483857 PMC: 11526068. DOI: 10.1016/j.crphys.2024.100132.


Phenotype Distinctions in Mice Deficient in the Neuron-Specific α3 Subunit of Na,K-ATPase: 3 and .

Liu Y, Arystarkhova E, Sacino A, Szabari M, Lutz C, Terrey M eNeuro. 2024; 11(8).

PMID: 39111836 PMC: 11360364. DOI: 10.1523/ENEURO.0101-24.2024.


Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation.

Yin R, Zhang K, Li Y, Tang Z, Zheng R, Ma Y Front Immunol. 2023; 14:1181973.

PMID: 37359525 PMC: 10285697. DOI: 10.3389/fimmu.2023.1181973.


References
1.
Borsini F . Role of the serotonergic system in the forced swimming test. Neurosci Biobehav Rev. 1995; 19(3):377-95. DOI: 10.1016/0149-7634(94)00050-b. View

2.
Bai F, Li X, Clay M, Lindstrom T, Skolnick P . Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav. 2001; 70(2-3):187-92. DOI: 10.1016/s0091-3057(01)00599-8. View

3.
Renard C, Dailly E, David D, Hascoet M, Bourin M . Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol. 2003; 17(4):449-55. DOI: 10.1046/j.1472-8206.2003.00160.x. View

4.
MARTIN P, Massol J, Colin J, Lacomblez L, Puech A . Antidepressant profile of bupropion and three metabolites in mice. Pharmacopsychiatry. 1990; 23(4):187-94. DOI: 10.1055/s-2007-1014505. View

5.
Crawley J, Belknap J, Collins A, Crabbe J, Frankel W, Henderson N . Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berl). 1997; 132(2):107-24. DOI: 10.1007/s002130050327. View